RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ) (RSLBF) Financial Performance & Income Statement Overview
Explore the financials of RaySearch Laboratories AB (publ) (RSLBF), including yearly and quarterly data on income, cash flow, and balance sheets.
RaySearch Laboratories AB (publ) (RSLBF) Income Statement & Financial Overview
Analyze RaySearch Laboratories AB (publ)’s RSLBF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $322.67M | $293.30M | $318.87M | $257.20M |
| Cost of Revenue | $24.79M | $27.86M | $23.74M | $96.20M |
| Gross Profit | $297.87M | $265.45M | $295.12M | $160.99M |
| Gross Profit Ratio | $0.92 | $0.91 | $0.93 | $0.63 |
| R&D Expenses | $71.29M | $68.52M | $68.39M | $61.18M |
| SG&A Expenses | $163.68M | $134.27M | $146.73M | $58.39M |
| Operating Expenses | $224.29M | $203.62M | $215.80M | $119.57M |
| Total Costs & Expenses | $249.09M | $231.48M | $239.54M | $215.77M |
| Interest Income | $0.00 | $0.00 | $2.17M | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $155000.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $27.90M | $73.10M |
| EBITDA | $73.58M | $61.83M | $79.32M | $73.67M |
| EBITDA Ratio | $0.23 | $0.21 | $0.25 | $0.29 |
| Operating Income | $73.58M | $61.83M | $79.32M | $41.42M |
| Operating Income Ratio | $0.23 | $0.21 | $0.25 | $0.16 |
| Other Income/Expenses (Net) | $3.86M | -$3.50M | $2.17M | $4.19M |
| Income Before Tax | $77.44M | $58.33M | $81.49M | $45.61M |
| Income Before Tax Ratio | $0.24 | $0.20 | $0.26 | $0.18 |
| Income Tax Expense | $17.44M | $12.94M | $20.06M | $8.91M |
| Net Income | $60.00M | $45.39M | $61.43M | $36.70M |
| Net Income Ratio | $0.19 | $0.15 | $0.19 | $0.14 |
| EPS | $1.75 | $1.32 | $1.79 | $1.07 |
| Diluted EPS | $1.75 | $1.32 | $1.79 | $1.07 |
| Weighted Avg Shares Outstanding | $34.28M | $34.28M | $34.32M | $34.28M |
| Weighted Avg Shares Outstanding (Diluted) | $34.28M | $34.28M | $34.32M | $34.28M |
Over the last four quarters, RaySearch Laboratories AB (publ)'s revenue moved from $257.20M in Q1 2024 to $322.67M in Q4 2024. Operating income in Q4 2024 was $73.58M, with a strong operating margin of 23%. Despite fluctuations in R&D and SG&A expenses, EBITDA for RaySearch Laboratories AB (publ) remained robust at $73.58M, reflecting operational efficiency. Net income rose to $60.00M, with an EPS of $1.75. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan